ICI inhibit ILT-2 and ILT-4 mediated inhibition of NK and CD8+ T cells as well as of myeloid cells; Reprogram myeloid cells in the TME; Promote phagocytosis of cancer cells and antigen presentation by DC; Increases cancer cell radio-sensitivity. This evidence concerns the gene LILRB2 and cancer.